Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMGO Imago BioSciences > Detailed Quotes

IMGO Imago BioSciences

16.560
+0.260+1.60%
Close 10/06 16:00 ET
16.5600.0000.00%
Post Mkt Price 10/06 16:01 ET
High
16.880
Open
16.310
Turnover
534.86K
Low
15.090
Pre Close
16.300
Volume
32.28K
Market Cap
558.76M
P/E(TTM)
Loss
52wk High
30.210
Shares
33.74M
P/E(Static)
Loss
52wk Low
11.560
Float Cap
283.45M
Bid/Ask %
-83.33%
Historical High
35.680
Shs Float
17.12M
Volume Ratio
0.37
Historical Low
11.560
Dividend TTM
--
Div Yield TTM
--
P/B
2.98
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.19%
Amplitude
10.98%
Avg Price
16.568
Lot Size
1
Float Cap
283.45M
Bid/Ask %
-83.33%
Historical High
35.680
Shs Float
17.12M
Volume Ratio
0.37
Historical Low
11.560
Dividend TTM
--
P/B
2.98
Dividend LFY
--
Turnover Ratio
0.19%
Amplitude
10.98%
Avg Price
16.568
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in South San Francisco, CA.
CEO: Mr. Hugh Y. Rienhoff
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...